nad has been researched along with Insulin Resistance in 53 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.89) | 18.7374 |
1990's | 2 (3.77) | 18.2507 |
2000's | 4 (7.55) | 29.6817 |
2010's | 28 (52.83) | 24.3611 |
2020's | 18 (33.96) | 2.80 |
Authors | Studies |
---|---|
Jin, X; Lian, H; Liu, K; Ye, J; Zhang, X | 1 |
Garcia-Arroyo, FE; Johnson, RJ; Lanaspa, MA; Nakagawa, T; Rodriguez-Iturbe, B; Sánchez-Lozada, LG | 1 |
Aflatounian, A; Bertoldo, MJ; Cochran, BJ; Edwards, MC; Gilchrist, RB; Ledger, WL; Paris, VR; Richani, D; Walters, KA; Wu, LE | 1 |
Ban, J; Chen, S; Chen, X; Jia, Z; Li, Z; Niu, S; Pan, X; Ren, Q; Yue, L; Zhen, R; Zhu, R | 1 |
Apte, RS; Bhargava, A; Bhasin, S; Cheng, M; Ghattas-Puylara, C; Latham, N; Lavu, S; Lawney, B; Lin, AP; Livingston, D; Memish-Beleva, Y; Merugumala, S; Orkaby, AR; Ozimek, NE; Pencina, KM; Reid, KF; Sinclair, DA; Storer, T; Swain, PM; Valderrabano, R; Wilson, L; Wipper, B | 1 |
Muralidaran, V; Patel, K; Ryan, CE; Sunny, NE; Surugihalli, C; Zhao, D | 1 |
Dong, M; Pei, Z; Wang, S | 1 |
Chen, L; Chuang, YH; Du, L; Guo, LZ; Ho, JA; Li, M; Li, Y; Liu, TM; Liu, Y; Qin, G; Wang, TD; Wang, X; Wu, PC; Zheng, W | 1 |
Hyeon, J; Kim, E; Kim, KP; Lee, HM; Lee, J; Lee, YI; Nam, CH; Park, HS; Shin, J | 1 |
Bae, HR; Han, Y; Kim, S; Kwon, EY; Shin, SK; Yoo, JH; Young, HA | 1 |
Boutant, M; Canto, C; Cercillieux, A; Giner, MP; Giroud-Gerbetant, J; Joffraud, M; Kulkarni, SS; Moco, S; Ratajczak, J; Sambeat, A; Sanchez-Garcia, JL; Valera-Alberni, M; Valsesia, A | 1 |
Agerholm, M; Altıntaş, A; Barrès, R; Chubanava, S; Dollerup, OL; Høyer, KF; Jessen, N; Larsen, S; Lavery, GG; Møller, AB; Prats, C; Ringgaard, S; Stødkilde-Jørgensen, H; Søndergård, SD; Treebak, JT | 1 |
Lee, AY; Lin, F; Ngo, K; Nguyen, HP; Shin, G; Sul, HS; Tabuchi, C; Viscarra, JA; Wang, Y; Yi, D | 1 |
Boriek, AM; Pardo, PS | 1 |
Fernández, AF; Fraga, MF; Roberti, A | 1 |
Franczyk, MP; Imai, SI; Kayser, BD; Klein, S; Mills, KF; Patterson, BW; Patti, GJ; Pietka, T; Sindelar, M; Yoshino, J; Yoshino, M | 1 |
Abel, ED; Karwi, QG; Lopaschuk, GD; Tian, R; Wende, AR | 1 |
Chen, D; Montllor-Albalate, C; Song, Z | 1 |
Fischer-Posovszky, P; Roos, J; Zinngrebe, J | 1 |
Adler, GK; Hamid, AAA; Homma, M; Homma, T; Huang, Y; Hurwitz, S; Mayurasakorn, K; Pojoga, LH; Rodi, NM; Romero, JR; Williams, GH; Yao, T | 1 |
Cui, J; Fan, R; Huang, Y; Qian, X; Ren, F; Wang, Q; Wei, L; Xiong, X; Zhao, B | 1 |
Gulshan, M; Hikosaka, K; Kitamura, T; Mahmood, A; Nakagawa, T; Okabe, K; Sasaki, T; Tobe, K; Usui, I; Yaku, K; Yamamoto, M | 1 |
Oxenkrug, G | 1 |
Imai, S; Yoshino, J | 1 |
Chi, Y; Sauve, AA | 1 |
Choi, JM; Kim, L; Lee, WY; Oh, KW; Park, CY; Park, SE; Park, SW; Rhee, EJ; Yang, SJ | 1 |
Alhonen, L; Asara, JM; Banks, AS; Bhanot, S; Cen, Y; Gong, F; Kahn, BB; Kong, D; Kraus, D; Monia, BP; Peroni, OD; Pirinen, E; Puigserver, P; Pulinilkunnil, TC; Rodgers, JT; Sauve, AA; Wang, YC; Yang, Q; Zhang, L | 1 |
Choo, HJ; Hong, J; Kim, BW; Ko, YG; Lee, H; Lee, JS; Park, JJ; Yi, JS; Yoon, GS; Yu, DM | 1 |
Ai, Y; Jia, SH; Marshall, JC; Parodo, J; Peng, Q | 1 |
Cui, J; Gong, H; Pang, J; Xi, C; Zhang, TM | 1 |
Corkey, BE; Jones Iv, AR; Kleckner, AS; Liesa, M; Nocito, L; Yoo, EJ | 1 |
Akie, TE; Cooper, MP; Lei, S; Liu, L; Nam, M | 1 |
Cho, JH; Chou, JY; Jun, HS; Kim, GY; Lee, YM; Mansfield, BC; Pan, CJ; Springer, DA | 1 |
Buzadzic, B; Daiber, A; Jankovic, A; Korac, A; Korac, B; Otasevic, V; Stancic, A | 1 |
Hakkarainen, A; Heinonen, S; Jukarainen, S; Kaprio, J; Lundbom, J; Lundbom, N; Muniandy, M; Pietiläinen, KH; Pirinen, E; Rämö, JT; Rappou, E; Rinnankoski-Tuikka, R; Rissanen, A; Tummers, M | 1 |
Ido, Y | 1 |
Hu, N; Ren, J; Zhang, Y | 1 |
Yamaguchi, S; Yoshino, J | 1 |
Imai, S; Kiess, W | 1 |
Fujie, H; Koike, K; Matsuura, Y; Miyamura, T; Miyoshi, H; Moriishi, K; Moriya, K; Shintani, Y; Shinzawa, S; Suzuki, T; Tsutsumi, T; Yotsuyanagi, H | 1 |
Azuma, K; Goodpaster, BH; Kelley, DE; Menshikova, EV; Ritov, VB; Ruderman, NB; Toledo, FG; Wood, R | 1 |
Baur, JA | 1 |
Kazdová, L; Kontrová, K; Mikulík, K; Pravenec, M; Sajdok, J; Skop, V; Zídek, V; Zídková, J | 1 |
Chung, JH; Foretz, M; Kang, H; Kim, MK; McBurney, MW; Park, SJ; Um, JH; Viollet, B; Yang, S | 1 |
Cheng, Z; White, MF | 1 |
Duarte, FV; Gomes, AP; Hubbard, BP; Jones, JG; Nunes, P; Palmeira, CM; Rolo, AP; Sinclair, DA; Teodoro, JS; Varela, AT | 1 |
Corkey, BE; Shirihai, O | 1 |
Berglund, ED; Coate, KC; Evans, RM; He, TT; Katafuchi, T; Kliewer, SA; Mangelsdorf, DJ; Potthoff, MJ; Wan, Y; Wei, W; Xiao, G; Xie, Y; Yu, RT; Zhang, Y | 1 |
Crescenzo, R; Iossa, S; Lionetti, L; Liverini, G; Mollica, MP; Tasso, R | 1 |
Gill, V; Singal, PK; Vasdev, S | 1 |
Kano, H; Kohno, M; Minami, M; Yasunari, K; Yokokawa, K; Yoshikawa, J | 1 |
Kadowaki, T | 1 |
Gawler, DJ; Houslay, MD; Milligan, G; Wilson, A | 1 |
16 review(s) available for nad and Insulin Resistance
Article | Year |
---|---|
The mechanisms of nucleotide actions in insulin resistance.
Topics: Adenosine Triphosphate; Diabetes Mellitus, Type 2; Humans; Insulin; Insulin Resistance; NAD; Nucleotides | 2022 |
Sirtuin deficiency and the adverse effects of fructose and uric acid synthesis.
Topics: Fructose; Humans; Insulin Resistance; NAD; Sirtuins; Uric Acid | 2022 |
Mechanism of CD38 via NAD
Topics: ADP-ribosyl Cyclase 1; Animals; Humans; Insulin Resistance; Lipids; Liver; Membrane Glycoproteins; Mice; NAD; Non-alcoholic Fatty Liver Disease | 2023 |
SIRT1 Regulation in Ageing and Obesity.
Topics: Aging; Animals; Diabetes Mellitus, Type 2; DNA Damage; Exercise; Gene Expression Regulation; Humans; Hypoxia; Inflammation; Insulin Resistance; Metabolic Syndrome; Mice; NAD; Obesity; Oxidative Stress; Protein Domains; Protein Processing, Post-Translational; Risk; Sirtuin 1; Stress, Mechanical | 2020 |
Nicotinamide N-methyltransferase: At the crossroads between cellular metabolism and epigenetic regulation.
Topics: Adipose Tissue; Animals; Epigenesis, Genetic; Humans; Insulin Resistance; Liver; NAD; Neoplasms; Niacinamide; Nicotinamide N-Methyltransferase; Obesity; S-Adenosylmethionine | 2021 |
Cardiac Energy Metabolism in Heart Failure.
Topics: Adenosine Triphosphate; Amino Acids, Branched-Chain; Comorbidity; Diabetes Mellitus, Type 2; Energy Metabolism; Epigenesis, Genetic; Fatty Acids; Glucose; Glycolysis; Heart Failure; Humans; Insulin Resistance; Ketone Bodies; Mitochondria; Myocardium; NAD; Obesity; Oxidation-Reduction | 2021 |
Insulin resistance and dysregulation of tryptophan-kynurenine and kynurenine-nicotinamide adenine dinucleotide metabolic pathways.
Topics: Biomarkers; Humans; Insulin Resistance; Kynurenine; Metabolic Networks and Pathways; NAD; Tryptophan | 2013 |
The importance of NAMPT/NAD/SIRT1 in the systemic regulation of metabolism and ageing.
Topics: Aging; Animals; Humans; Insulin; Insulin Resistance; Insulin Secretion; Metabolism; NAD; Nicotinamide Phosphoribosyltransferase; Nutritional Status; Sirtuin 1 | 2013 |
Nicotinamide riboside, a trace nutrient in foods, is a vitamin B3 with effects on energy metabolism and neuroprotection.
Topics: Alzheimer Disease; Animals; Brain; Disease Models, Animal; Energy Metabolism; Humans; Insulin Resistance; Intracellular Signaling Peptides and Proteins; Mitochondrial Turnover; Muscle, Skeletal; NAD; Neuroprotective Agents; Niacinamide; Phosphotransferases (Alcohol Group Acceptor); Pyridinium Compounds | 2013 |
Redox implications in adipose tissue (dys)function--A new look at old acquaintances.
Topics: Adipocytes; Adipogenesis; Adipose Tissue; Diabetes Mellitus, Type 2; Energy Metabolism; Humans; Hydrogen Peroxide; Insulin Resistance; Metabolic Syndrome; Mitochondria; NAD; NADPH Oxidases; Obesity; Oxidation-Reduction | 2015 |
Diabetic complications within the context of aging: Nicotinamide adenine dinucleotide redox, insulin C-peptide, sirtuin 1-liver kinase B1-adenosine monophosphate-activated protein kinase positive feedback and forkhead box O3.
Topics: Aging; AMP-Activated Protein Kinases; Animals; C-Peptide; Diabetes Complications; Diabetic Angiopathies; Disease Models, Animal; Epigenesis, Genetic; Feedback, Physiological; Forkhead Box Protein O3; Humans; Hypoxia; Insulin Resistance; NAD; Oxidation-Reduction; Oxidative Stress; Signal Transduction; Sirtuin 1 | 2016 |
Adipose tissue NAD
Topics: Adipose Tissue; Animals; Humans; Insulin Resistance; Models, Biological; NAD; Nicotinamide Phosphoribosyltransferase; Obesity; PPAR gamma; Protein Processing, Post-Translational; Sirtuin 1; Translational Research, Biomedical | 2017 |
Therapeutic potential of SIRT1 and NAMPT-mediated NAD biosynthesis in type 2 diabetes.
Topics: Aging; Cytokines; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; NAD; Nicotinamide Phosphoribosyltransferase; Sirtuin 1; Sirtuins | 2009 |
Biochemical effects of SIRT1 activators.
Topics: Animals; Cardiotonic Agents; Energy Metabolism; Enzyme Activation; Heterocyclic Compounds, 4 or More Rings; Humans; Insulin Resistance; Learning; Longevity; Memory; Mice; Models, Biological; NAD; Neoplasms; Niacinamide; O-Acetyl-ADP-Ribose; Resveratrol; Silent Information Regulator Proteins, Saccharomyces cerevisiae; Sirtuin 1; Stilbenes | 2010 |
Beneficial effect of low ethanol intake on the cardiovascular system: possible biochemical mechanisms.
Topics: Atherosclerosis; Cardiovascular Diseases; Cardiovascular System; Dyslipidemias; Endothelium, Vascular; Ethanol; Glycation End Products, Advanced; Humans; Hypertension; Insulin Resistance; NAD; Oxidative Stress | 2006 |
[Molecular pathogenesis of type 2 diabetes mellitus].
Topics: Animals; Diabetes Mellitus, Type 2; Environment; Glucokinase; Glucose; Hyperglycemia; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Life Style; Liver; Mitochondria; NAD; Receptor, Insulin | 1999 |
3 trial(s) available for nad and Insulin Resistance
Article | Year |
---|---|
Nicotinamide Adenine Dinucleotide Augmentation in Overweight or Obese Middle-Aged and Older Adults: A Physiologic Study.
Topics: Aged; Body Weight; Cholesterol; Humans; Insulin Resistance; Middle Aged; NAD; Nicotinamide Mononucleotide; Obesity; Overweight | 2023 |
Nicotinamide riboside does not alter mitochondrial respiration, content or morphology in skeletal muscle from obese and insulin-resistant men.
Topics: Humans; Insulin Resistance; Male; Middle Aged; Mitochondria, Muscle; Muscle, Skeletal; NAD; Niacinamide; Nicotinamide Phosphoribosyltransferase; Obesity; Pyridinium Compounds | 2020 |
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.
Topics: Aged; Body Composition; Dietary Supplements; Double-Blind Method; Female; Humans; Insulin; Insulin Resistance; Middle Aged; Mitochondria, Muscle; Muscle, Skeletal; NAD; Nicotinamide Mononucleotide; Obesity; Overweight; Postmenopause; Prediabetic State; RNA-Seq; Signal Transduction | 2021 |
34 other study(ies) available for nad and Insulin Resistance
Article | Year |
---|---|
Declining muscle NAD
Topics: Animals; Dihydrotestosterone; Female; Humans; Hyperandrogenism; Insulin Resistance; Lipids; Metabolic Syndrome; Mice; Muscle, Skeletal; NAD; Nicotinamide Mononucleotide; Obesity; Polycystic Ovary Syndrome | 2022 |
Metabolomics Provides Insights into Renoprotective Effects of Semaglutide in Obese Mice.
Topics: Adenosine; Animals; Insulin Resistance; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Obese; NAD; Obesity | 2022 |
Branched-chain amino acids alter cellular redox to induce lipid oxidation and reduce de novo lipogenesis in the liver.
Topics: Amino Acids, Branched-Chain; Animals; Insulin; Insulin Resistance; Lipid Metabolism; Lipids; Lipogenesis; Liver; Mice; Mice, Inbred C57BL; NAD; Oxidation-Reduction | 2023 |
Label-free optical metabolic imaging of adipose tissues for prediabetes diagnosis.
Topics: Adipose Tissue; Animals; Hyperglycemia; Insulin Resistance; Lipofuscin; Mice; NAD; Prediabetic State | 2023 |
Vutiglabridin exerts anti-ageing effects in aged mice through alleviating age-related metabolic dysfunctions.
Topics: Aging; Animals; Inflammation; Insulin Resistance; Mice; NAD; Reactive Oxygen Species | 2023 |
D-Allulose Ameliorates Dysregulated Macrophage Function and Mitochondrial NADH Homeostasis, Mitigating Obesity-Induced Insulin Resistance.
Topics: Adipose Tissue; Animals; Diabetes Mellitus, Type 2; Diet, High-Fat; Homeostasis; Humans; Inflammation; Insulin Resistance; Insulins; Macrophages; Mice; Mice, Inbred C57BL; Mitochondria; NAD; Obesity | 2023 |
Endogenous nicotinamide riboside metabolism protects against diet-induced liver damage.
Topics: Animals; Blood Glucose; Diet, High-Fat; Disease Models, Animal; DNA Damage; Gene Knockout Techniques; Genetic Predisposition to Disease; Glucose Intolerance; Hepatocytes; Insulin Resistance; Lipid Metabolism; Liver; Liver Diseases; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mice, Knockout; NAD; Niacinamide; Phosphotransferases (Alcohol Group Acceptor); Protective Agents; Pyridinium Compounds | 2019 |
Aifm2, a NADH Oxidase, Supports Robust Glycolysis and Is Required for Cold- and Diet-Induced Thermogenesis.
Topics: Adipose Tissue, Brown; Adipose Tissue, White; Animals; Apoptosis Regulatory Proteins; Diet; Energy Metabolism; Glucose; Glycolysis; HEK293 Cells; Humans; Insulin Resistance; Lipid Droplets; Male; Mice, Inbred C57BL; Mice, Knockout; Mitochondrial Membranes; Mitochondrial Proteins; Multienzyme Complexes; NAD; NADH, NADPH Oxidoreductases; Obesity; Oxidation-Reduction; Oxygen Consumption; Thermogenesis; Uncoupling Protein 1 | 2020 |
The therapeutic promises of NAD
Topics: Aging; Female; Humans; Insulin Resistance; Muscles; NAD; Prediabetic State | 2021 |
Nicotinamide mononucleotide: a potential effective natural compound against insulin resistance.
Topics: Biological Products; Female; Humans; Insulin; Insulin Resistance; NAD; Nicotinamide Mononucleotide; Overweight; Randomized Controlled Trials as Topic | 2021 |
Combined Salt and Caloric Restrictions: Potential Adverse Outcomes.
Topics: Adiponectin; Aldosterone; Animal Nutritional Physiological Phenomena; Animals; Biomarkers; Blood Glucose; Blood Pressure; Caloric Restriction; Cardiovascular Diseases; Cytokines; Diet, Sodium-Restricted; Insulin; Insulin Resistance; Kidney; Male; NAD; Nicotinamide Phosphoribosyltransferase; Nutritional Status; Rats, Wistar; Renin; Renin-Angiotensin System; Risk Assessment; Risk Factors; Sodium, Dietary; Time Factors; Zona Glomerulosa | 2017 |
Overexpression of NRK1 ameliorates diet- and age-induced hepatic steatosis and insulin resistance.
Topics: Aging; Animals; Diet, High-Fat; Fatty Liver; HEK293 Cells; Humans; Insulin Resistance; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; NAD; Niacinamide; NIH 3T3 Cells; Phosphotransferases (Alcohol Group Acceptor); Pyridinium Compounds; Triglycerides | 2018 |
Overexpression of Nmnat3 efficiently increases NAD and NGD levels and ameliorates age-associated insulin resistance.
Topics: Animals; Calorimetry; Cellular Senescence; Guanine Nucleotides; Insulin Resistance; Mice; Mice, Transgenic; Muscle, Skeletal; NAD; Nicotinamide-Nucleotide Adenylyltransferase; Reactive Oxygen Species | 2018 |
Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; DNA, Mitochondrial; Energy Metabolism; Glucose; Glucose Tolerance Test; Insulin Resistance; Liver; Male; Mitochondrial Turnover; NAD; Niacinamide; Nicotinamide Phosphoribosyltransferase; Obesity; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rats; Rats, Inbred OLETF; Signal Transduction; Sirtuin 1; Sirtuins; Transcription Factors | 2014 |
Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity.
Topics: Acetyltransferases; Adipocytes; Adipose Tissue; Adipose Tissue, White; Animals; Diabetes Mellitus, Type 2; Diet; Energy Metabolism; Fatty Liver; Gene Knockdown Techniques; Glucose Intolerance; Glucose Transporter Type 4; Insulin Resistance; Liver; Male; Mice; Mice, Inbred C57BL; NAD; Niacinamide; Nicotinamide N-Methyltransferase; Obesity; Ornithine Decarboxylase; Oxidoreductases Acting on CH-NH Group Donors; Polyamine Oxidase; S-Adenosylmethionine; Sirtuin 1; Spermine; Thinness | 2014 |
Mitochondrial complex I deficiency enhances skeletal myogenesis but impairs insulin signaling through SIRT1 inactivation.
Topics: Animals; Cell Line; Electron Transport Complex I; Gene Knockdown Techniques; Insulin; Insulin Resistance; Mice; Mitochondrial Diseases; Models, Biological; Muscle Development; Muscle Fibers, Skeletal; Muscle, Skeletal; NAD; Oxidative Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 1; RNA, Small Interfering; Signal Transduction; Sirtuin 1 | 2014 |
Pre-B cell colony enhancing factor induces Nampt-dependent translocation of the insulin receptor out of lipid microdomains in A549 lung epithelial cells.
Topics: Acrylamides; Antigens, CD; Caveolin 1; Cell Line; Cytokines; Enzyme Inhibitors; Humans; Insulin; Insulin Resistance; Lung; Membrane Microdomains; NAD; Nicotinamide Phosphoribosyltransferase; Phosphorylation; Piperidines; Protein Processing, Post-Translational; Protein Transport; Proto-Oncogene Proteins c-akt; Receptor, Insulin; Recombinant Proteins; Respiratory Mucosa; Signal Transduction | 2015 |
Effect of NAD on PARP-mediated insulin sensitivity in oleic acid treated hepatocytes.
Topics: Gene Expression Regulation; Hep G2 Cells; Hepatocytes; Humans; Insulin; Insulin Resistance; Lipid Metabolism; NAD; Oleic Acid; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Reactive Oxygen Species; Sirtuin 1 | 2015 |
The extracellular redox state modulates mitochondrial function, gluconeogenesis, and glycogen synthesis in murine hepatocytes.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Animals; Cysteine; Cystine; Diabetes Mellitus, Type 2; Gluconeogenesis; Glutathione; Glutathione Disulfide; Glycogen; Hepatocytes; Humans; Hydrogen Peroxide; Insulin Resistance; Mice; Mitochondria; NAD; Oxidation-Reduction; Respiration | 2015 |
OXPHOS-Mediated Induction of NAD+ Promotes Complete Oxidation of Fatty Acids and Interdicts Non-Alcoholic Fatty Liver Disease.
Topics: Animals; Diet, High-Fat; Fatty Acids; Gene Expression Regulation; Hepatocytes; Humans; Insulin Resistance; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria; NAD; Neoplasm Proteins; Non-alcoholic Fatty Liver Disease; Oxidation-Reduction; Oxidative Phosphorylation; Primary Cell Culture; Protein Kinase C-epsilon; Signal Transduction; Sirtuin 3 | 2015 |
Mice expressing reduced levels of hepatic glucose-6-phosphatase-α activity do not develop age-related insulin resistance or obesity.
Topics: AMP-Activated Protein Kinases; Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Dependovirus; Disease Models, Animal; Energy Metabolism; Gene Expression; Genetic Therapy; Genetic Vectors; Glucose-6-Phosphatase; Glycogen Storage Disease Type I; Insulin Resistance; Liver; Mice; Mice, Knockout; NAD; Nuclear Proteins; Obesity; Signal Transduction; Sirtuin 1; Transcription Factors | 2015 |
Obesity Is Associated With Low NAD(+)/SIRT Pathway Expression in Adipose Tissue of BMI-Discordant Monozygotic Twins.
Topics: Absorptiometry, Photon; Adipose Tissue; Adult; Body Composition; Body Mass Index; Cohort Studies; Cross-Sectional Studies; Down-Regulation; Female; Finland; Glucose Tolerance Test; Humans; Insulin Resistance; Life Style; Male; NAD; Obesity; Sirtuins; Twins, Monozygotic | 2016 |
Mitochondrial aldehyde dehydrogenase obliterates insulin resistance-induced cardiac dysfunction through deacetylation of PGC-1α.
Topics: Aconitate Hydratase; Aldehyde Dehydrogenase, Mitochondrial; Animals; Calcium; Cardiomyopathies; Echocardiography; Energy Metabolism; Glucose Tolerance Test; Heme Oxygenase-1; Insulin Resistance; Male; Mice; Mice, Transgenic; Mitochondria; Myocardium; Myocytes, Cardiac; NAD; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphorylation; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species | 2016 |
Tacrolimus ameliorates metabolic disturbance and oxidative stress caused by hepatitis C virus core protein: analysis using mouse model and cultured cells.
Topics: Animals; Antioxidants; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Fatty Liver; Gene Expression Regulation; Glucose; Hep G2 Cells; Humans; Insulin Resistance; Lipid Metabolism; Liver; Mice; Mice, Transgenic; NAD; Oxidative Stress; Reactive Oxygen Species; RNA, Messenger; Tacrolimus; Viral Core Proteins | 2009 |
Deficiency of electron transport chain in human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity.
Topics: 3-Hydroxyacyl CoA Dehydrogenases; Adult; Biopsy; Blood Glucose; Cardiolipins; Citrate (si)-Synthase; Diabetes Mellitus, Type 2; DNA, Mitochondrial; Electron Transport; Humans; Insulin Resistance; Lipid Metabolism; Middle Aged; Mitochondria; Multienzyme Complexes; NAD; NADH, NADPH Oxidoreductases; Obesity; Oxidative Phosphorylation; Quadriceps Muscle; Trichloroacetic Acid | 2010 |
Autocrine effects of visfatin on hepatocyte sensitivity to insulin action.
Topics: Animals; Autocrine Communication; Biological Transport; Cell Line; Cytokines; Gene Expression Regulation, Enzymologic; Glucose; Hepatocytes; Insulin; Insulin Resistance; NAD; Nicotinamide Phosphoribosyltransferase; Rats; Rats, Inbred WKY; RNA Interference; RNA, Messenger | 2010 |
AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol.
Topics: AMP-Activated Protein Kinases; Animals; Cells, Cultured; Drug Resistance; Enzyme Inhibitors; Fibroblasts; Glucose Intolerance; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mitochondria; Muscle, Skeletal; NAD; Resveratrol; Sirtuin 1; Stilbenes; Weight Loss | 2010 |
Foxo1 in hepatic lipid metabolism.
Topics: Animals; Forkhead Box Protein O1; Forkhead Transcription Factors; Gluconeogenesis; Heme Oxygenase-1; Insulin Resistance; Lipid Metabolism; Liver; Membrane Proteins; Mice; NAD; Signal Transduction | 2010 |
Berberine protects against high fat diet-induced dysfunction in muscle mitochondria by inducing SIRT1-dependent mitochondrial biogenesis.
Topics: AMP-Activated Protein Kinases; Animals; Berberine; Cell Line; Diet, High-Fat; Glucose; Hormones; Hyperglycemia; Insulin Resistance; Male; Mice; Mitochondria; Mitochondria, Muscle; Muscle, Skeletal; Myoblasts; NAD; Obesity; Organelle Biogenesis; Phosphorylation; Rats; Rats, Sprague-Dawley; Sirtuin 1 | 2012 |
Metabolic master regulators: sharing information among multiple systems.
Topics: Adipose Tissue; Diabetes Mellitus, Type 2; Female; Homeostasis; Humans; Insulin Resistance; Lactic Acid; Liver; Metabolome; Mitochondria; Models, Biological; Muscles; NAD; NADP; Obesity; Oxidation-Reduction; Pyruvic Acid; Signal Transduction | 2012 |
The starvation hormone, fibroblast growth factor-21, extends lifespan in mice.
Topics: Adaptation, Physiological; Adenylate Kinase; Animals; Bone Resorption; Caloric Restriction; Fasting; Fatty Acids; Female; Fibroblast Growth Factors; Gene Expression Regulation; Growth Hormone; Insulin Resistance; Insulin-Like Growth Factor I; Ketone Bodies; Lipid Metabolism; Liver; Longevity; Male; Mice; Mice, Transgenic; NAD; Oxidation-Reduction; Signal Transduction; TOR Serine-Threonine Kinases; Transgenes | 2012 |
A possible link between skeletal muscle mitochondrial efficiency and age-induced insulin resistance.
Topics: Adult; Aged; Aging; Animals; Flavin-Adenine Dinucleotide; Humans; Insulin Resistance; Lipid Metabolism; Middle Aged; Mitochondria, Muscle; Models, Animal; Muscle, Skeletal; Myofibrils; NAD; Oxygen Consumption; Rats; Risk Factors; Sarcolemma | 2004 |
Antioxidants improve impaired insulin-mediated glucose uptake and prevent migration and proliferation of cultured rabbit coronary smooth muscle cells induced by high glucose.
Topics: Animals; Antioxidants; Becaplermin; Biological Transport, Active; Cell Cycle; Cell Division; Cell Movement; Cells, Cultured; Coronary Vessels; Enzyme Activation; Enzyme Inhibitors; Flow Cytometry; Fructose; Glucose; Insulin; Insulin Resistance; Muscle, Smooth, Vascular; NAD; Naphthalenes; Oxidation-Reduction; Oxidative Stress; Phospholipase D; Platelet-Derived Growth Factor; Probucol; Protein Kinase C; Proto-Oncogene Proteins c-sis; Rabbits; Suramin; Vitamin E | 1999 |
Multiple defects occur in the guanine nucleotide regulatory protein system in liver plasma membranes of obese (fa/fa) but not lean (Fa/Fa) Zucker rats: loss of functional Gi and abnormal Gs function.
Topics: Adenosine Diphosphate Ribose; Adenylate Cyclase Toxin; Adenylyl Cyclases; Animals; Blotting, Western; Cell Membrane; Cholera Toxin; Colforsin; Diabetes Mellitus, Experimental; Glucagon; GTP-Binding Proteins; Guanylyl Imidodiphosphate; Insulin Resistance; Liver; Male; NAD; Obesity; Pertussis Toxin; Phosphorus Radioisotopes; Rats; Rats, Inbred Strains; Rats, Zucker; Receptors, Gastrointestinal Hormone; Receptors, Glucagon; Virulence Factors, Bordetella | 1989 |